A clinical collection on addiction treatment, ADHD and SUDs, important drug indications, vaping, cannabis use, benzodiazepines, the perils of self-medicating and other topics relevant to practicing psychiatrists.
Not just a nuisance, no-shows are an opportunity to turn things around for patients with bipolar disorder, whose treatment adherence hovers around 60%.
The main goal in treating addiction is to help the patient achieve and improve functioning. When that patient is also an adolescent, there are special considerations. Here's a quick primer.
Among the clues revealed in 3 recent studies: brain amyloid, saliva biomarkers, and microvascular dysfunction.
Which of these agents best prevents relapse? A recent study employed a novel approach to find out.
In psychiatry, hot debates abound if you just look around—and if this Special Report collection is any indication, the result is a balance of opinion and civility made richer by virtue of opposing views.
Most individuals who have experienced a disaster-related event or epidemic are at increased risk for distress behaviors that have equally significant and chronic consequences. Here’s what psychiatrists need to know.
Three new studies show exercise can improve cognitive function, psychotropics for PTSD may raise dementia risk, and 3 biomarkers can help predict cognitive decline in elderly persons.
Clinicians need to consider and manage multiple medical and cognitive comorbidities when working with the elderly population. This slideshow provides an overview of key points relevant to geriatric bipolar disorder as it relates to comorbidity.
After lounging on the doorstep of respectability for the past decade, assisted outpatient treatment is here to stay. But some still balk at the notion.